Repros Therapeutics, Inc. (RPRX) Posts Q1 Loss of 37c/Share

Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q1 EPS of ($0.37), $0.02 worse than the analyst estimate of ($0.35).

For earnings history and earnings-related data on Repros Therapeutics, Inc. (RPRX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• SWBI beats estimates by 71%, GEO nears 52-week high on policy tailwinds
• Waste stocks ride AI and healthcare boom as CLH surges 27%